JPWO2022047241A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022047241A5 JPWO2022047241A5 JP2023513682A JP2023513682A JPWO2022047241A5 JP WO2022047241 A5 JPWO2022047241 A5 JP WO2022047241A5 JP 2023513682 A JP2023513682 A JP 2023513682A JP 2023513682 A JP2023513682 A JP 2023513682A JP WO2022047241 A5 JPWO2022047241 A5 JP WO2022047241A5
- Authority
- JP
- Japan
- Prior art keywords
- individual
- cyclodextrin
- hydroxypropyl
- amount
- cholesterol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063071222P | 2020-08-27 | 2020-08-27 | |
| US63/071,222 | 2020-08-27 | ||
| PCT/US2021/048072 WO2022047241A1 (en) | 2020-08-27 | 2021-08-27 | Methods for the treatment of cholesterol crystal embolization with cyclodextrins |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023543133A JP2023543133A (ja) | 2023-10-13 |
| JP2023543133A5 JP2023543133A5 (https=) | 2024-08-27 |
| JPWO2022047241A5 true JPWO2022047241A5 (https=) | 2024-08-27 |
| JP7835735B2 JP7835735B2 (ja) | 2026-03-25 |
Family
ID=80353289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023513682A Active JP7835735B2 (ja) | 2020-08-27 | 2021-08-27 | シクロデキストリンによるコレステロール結晶塞栓症の治療方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230330133A1 (https=) |
| EP (1) | EP4203972A4 (https=) |
| JP (1) | JP7835735B2 (https=) |
| KR (1) | KR20230096975A (https=) |
| CN (1) | CN116322643A (https=) |
| AU (1) | AU2021333902A1 (https=) |
| BR (1) | BR112023003455A2 (https=) |
| CA (1) | CA3190563A1 (https=) |
| IL (1) | IL300806A (https=) |
| MX (1) | MX2023002419A (https=) |
| WO (1) | WO2022047241A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2988529A1 (en) | 2015-06-10 | 2016-12-15 | Vtesse, Inc. | Hydroxypropyl beta-cyclodextrin compositions and methods |
| AU2022222756A1 (en) * | 2021-02-18 | 2023-09-14 | Beren Therapeutics P.B.C. | Methods for the treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrins |
| WO2023156966A1 (en) | 2022-02-18 | 2023-08-24 | Beren Therapeutics P.B.C. | Compositions of hydroxypropyl-beta-cyclodextrin and methods of purifying the same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4877778A (en) * | 1987-07-01 | 1989-10-31 | The Children's Medical Center Corporation | Method of enhancing lipophile transport using cyclodextrin derivatives |
| CN104244956B (zh) * | 2012-04-13 | 2020-04-17 | L&F研究有限公司 | 使用环糊精的方法 |
-
2021
- 2021-08-27 KR KR1020237010389A patent/KR20230096975A/ko not_active Withdrawn
- 2021-08-27 WO PCT/US2021/048072 patent/WO2022047241A1/en not_active Ceased
- 2021-08-27 CA CA3190563A patent/CA3190563A1/en active Pending
- 2021-08-27 BR BR112023003455A patent/BR112023003455A2/pt not_active Application Discontinuation
- 2021-08-27 AU AU2021333902A patent/AU2021333902A1/en not_active Abandoned
- 2021-08-27 JP JP2023513682A patent/JP7835735B2/ja active Active
- 2021-08-27 MX MX2023002419A patent/MX2023002419A/es unknown
- 2021-08-27 CN CN202180053198.8A patent/CN116322643A/zh active Pending
- 2021-08-27 EP EP21862876.6A patent/EP4203972A4/en active Pending
- 2021-08-27 US US18/043,013 patent/US20230330133A1/en active Pending
- 2021-08-27 IL IL300806A patent/IL300806A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020200500B2 (en) | Compositions based on methyl cyclodextrins for the treatment and/or prevention of diseases by increasing the hdl cholesterol level | |
| JP5105687B2 (ja) | 高活性および低減された副作用を有する組換えエリスロポエチンの治療的使用 | |
| Little et al. | Combination erythropoietin-hydroxyurea therapy in sickle cell disease: NIH experience and literature review | |
| Michelson et al. | Antithrombotic therapy in children | |
| Di Minno et al. | Gastrointestinal bleeding in patients receiving oral anticoagulation: current treatment and pharmacological perspectives | |
| JPH06293658A (ja) | 微小血管血栓症の抑制法 | |
| JP7835735B2 (ja) | シクロデキストリンによるコレステロール結晶塞栓症の治療方法 | |
| Curtis et al. | Reversal of warfarin anticoagulation for urgent surgical procedures | |
| Tegenge et al. | Pharmacokinetics of antibodies during pregnancy: general pharmacokinetics and pregnancy related physiological changes (part 1) | |
| Ozier et al. | Pharmacological agents: antifibrinolytics and desmopressin | |
| JPWO2022047241A5 (https=) | ||
| Pasternak et al. | Enhanced rate of progression of coronary artery disease following aortocoronary saphenous vein bypass surgery | |
| Takahashi et al. | Renal cholesterol embolic disease effectively treated with steroid pulse therapy | |
| AU2001282004B2 (en) | Method for treating unstable angina pectoris | |
| Hung et al. | NKCC1 inhibition as a breakthrough in combating coagulopathy and boosting survival in LPS-induced DIC rat model | |
| JPH07196650A (ja) | 平滑筋細胞増殖抑制作用を有するアルガトロバン製剤 | |
| Janatmakan et al. | Effect of local fibrinogen administration on postoperative bleeding in open prostatectomy surgery | |
| JPWO2022047244A5 (https=) | ||
| Pacchiarini et al. | Atheroembolic renal disease associated with dabigatran overdose | |
| CN114619041B (zh) | 一种铈修饰金纳米团簇及其制备方法、应用 | |
| Williams | Parathyroidectomy might reduce cardiovascular calcification in dialysis patients | |
| US11931376B1 (en) | Methods for the treatment of chronic kidney disease | |
| Benhar et al. | Coronary Artery Disease and Impaired Renal Function | |
| JPWO2022047249A5 (https=) | ||
| JP2012522770A (ja) | 急性心筋梗塞に対する初期対応におけるリボースの使用 |